ASX - By Stock
|
MSB |
Re:
MSB - Intellectual Property updates
|
|
ces
|
58 |
20K |
3 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
58
|
20K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB - Intellectual Property updates
|
|
ces
|
58 |
20K |
5 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
58
|
20K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB - Intellectual Property updates
|
|
ces
|
58 |
20K |
1 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
58
|
20K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Change of Director's Interest Notice
|
|
ces
|
16 |
5.4K |
0 |
20/09/21 |
20/09/21 |
ASX - By Stock
|
16
|
5.4K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Change of Director's Interest Notice
|
|
ces
|
16 |
5.4K |
1 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
16
|
5.4K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Change of Director's Interest Notice
|
|
ces
|
16 |
5.4K |
0 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
16
|
5.4K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Ann: HZN Presentation to Good Oil Conference 2021
|
|
ces
|
16 |
5.8K |
2 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
16
|
5.8K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ces
|
10K |
3.0M |
5 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
HZN |
Re:
Ann: HZN Presentation to Good Oil Conference 2021
|
|
ces
|
16 |
5.8K |
0 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
16
|
5.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
4 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
4 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
HZN |
Re:
Ann: HZN Presentation to Good Oil Conference 2021
|
|
ces
|
16 |
5.8K |
1 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
16
|
5.8K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ces
|
10K |
3.0M |
3 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
HZN |
Re:
Review of Adiministration Costs
|
|
ces
|
10 |
2.4K |
1 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
10
|
2.4K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Review of Adiministration Costs
|
|
ces
|
10 |
2.4K |
0 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
10
|
2.4K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Where to From Here
|
|
ces
|
39 |
14K |
1 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
39
|
14K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Where to From Here
|
|
ces
|
39 |
14K |
2 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
39
|
14K
|
2
|
|
ASX - By Stock
|
HZN |
Re:
Where to From Here
|
|
ces
|
39 |
14K |
1 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
39
|
14K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Where to From Here
|
|
ces
|
39 |
14K |
0 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
39
|
14K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Where to From Here
|
|
ces
|
39 |
14K |
4 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
39
|
14K
|
4
|
|
ASX - By Stock
|
HZN |
Re:
Where to From Here
|
|
ces
|
39 |
14K |
1 |
25/07/21 |
25/07/21 |
ASX - By Stock
|
39
|
14K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Changes to Share Capital Return and EGM
|
|
ces
|
66 |
24K |
1 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
66
|
24K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Changes to Share Capital Return and EGM
|
|
ces
|
66 |
24K |
1 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
66
|
24K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Changes to Share Capital Return and EGM
|
|
ces
|
66 |
24K |
3 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
66
|
24K
|
3
|
|
ASX - By Stock
|
HZN |
Re:
Spot valuation 22c
|
|
ces
|
53 |
19K |
3 |
18/07/21 |
18/07/21 |
ASX - By Stock
|
53
|
19K
|
3
|
|
ASX - By Stock
|
HZN |
Re:
Spot valuation 22c
|
|
ces
|
53 |
19K |
0 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
53
|
19K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Spot valuation 22c
|
|
ces
|
53 |
19K |
4 |
08/07/21 |
08/07/21 |
ASX - By Stock
|
53
|
19K
|
4
|
|
ASX - By Stock
|
HZN |
Re:
Spot valuation 22c
|
|
ces
|
53 |
19K |
0 |
08/07/21 |
08/07/21 |
ASX - By Stock
|
53
|
19K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Spot valuation 22c
|
|
ces
|
53 |
19K |
1 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
53
|
19K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Spot valuation 22c
|
|
ces
|
53 |
19K |
1 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
53
|
19K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Spot valuation 22c
|
|
ces
|
53 |
19K |
0 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
53
|
19K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Spot valuation 22c
|
|
ces
|
53 |
19K |
1 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
53
|
19K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Announcement of Share Capital Reduction
|
|
ces
|
35 |
14K |
2 |
06/07/21 |
06/07/21 |
ASX - By Stock
|
35
|
14K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
ces
|
1.5K |
415K |
4 |
06/07/21 |
06/07/21 |
ASX - By Stock
|
1.5K
|
415K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ces
|
10K |
3.0M |
4 |
05/07/21 |
05/07/21 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Novartis countdown
|
|
ces
|
373 |
112K |
3 |
04/07/21 |
04/07/21 |
ASX - By Stock
|
373
|
112K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ces
|
10K |
3.0M |
4 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Moderated
|
|
ces
|
1.5K |
504K |
4 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
1.5K
|
504K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
ces
|
9.8K |
2.9M |
4 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
9.8K
|
2.9M
|
4
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Board appoints Nigel Burgess
|
|
ces
|
5 |
2.5K |
5 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
5
|
2.5K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
$90 a share on COVID ARDS Authorization ?
|
|
ces
|
260 |
81K |
3 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
260
|
81K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
$90 a share on COVID ARDS Authorization ?
|
|
ces
|
260 |
81K |
1 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
260
|
81K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
$90 a share on COVID ARDS Authorization ?
|
|
ces
|
260 |
81K |
0 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
260
|
81K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ces
|
10K |
3.0M |
3 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
9 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
17K
|
6.7M
|
9
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Announcement of Share Capital Reduction
|
|
ces
|
35 |
14K |
2 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
35
|
14K
|
2
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Announcement of Share Capital Reduction
|
|
ces
|
35 |
14K |
3 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
35
|
14K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
ces
|
1.5K |
415K |
6 |
26/06/21 |
26/06/21 |
ASX - By Stock
|
1.5K
|
415K
|
6
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Form 484 Cancellation and Issue of shares
|
|
ces
|
19 |
6.0K |
1 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
19
|
6.0K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Form 484 Cancellation and Issue of shares
|
|
ces
|
19 |
6.0K |
3 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
19
|
6.0K
|
3
|
|